X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
male (1006) 1006
humans (882) 882
animals (532) 532
index medicus (496) 496
5 alpha-reductase (435) 435
finasteride (379) 379
endocrinology & metabolism (373) 373
testosterone (359) 359
cholestenone 5 alpha-reductase (354) 354
5α-reductase (342) 342
female (332) 332
benign prostatic hyperplasia (311) 311
rats (300) 300
urology & nephrology (272) 272
dihydrotestosterone (244) 244
middle aged (228) 228
biochemistry & molecular biology (218) 218
pharmacology & pharmacy (208) 208
prostate (206) 206
men (200) 200
steroid 5-alpha-reductase (194) 194
adult (191) 191
expression (187) 187
aged (185) 185
prostate cancer (176) 176
oxidoreductases - metabolism (173) 173
prostatic hyperplasia - drug therapy (165) 165
dutasteride (163) 163
androgens (160) 160
androgen receptor (158) 158
enzyme inhibitors - pharmacology (152) 152
cholestenone 5 alpha-reductase - antagonists & inhibitors (149) 149
testosterone - metabolism (142) 142
neurosciences (139) 139
3-oxo-5-alpha-steroid 4-dehydrogenase - metabolism (137) 137
cholestenone 5 alpha-reductase - metabolism (136) 136
hyperplasia (131) 131
finasteride - pharmacology (128) 128
oxidoreductases - antagonists & inhibitors (128) 128
5 alpha-reductase inhibitors (121) 121
dihydrotestosterone - metabolism (121) 121
mice (118) 118
5 alpha-reductase inhibitor (116) 116
chemistry, medicinal (115) 115
5-alpha reductase inhibitors (108) 108
male pseudohermaphroditism (108) 108
3-oxo-5-alpha-steroid 4-dehydrogenase - genetics (106) 106
rat (106) 106
finasteride - therapeutic use (104) 104
cancer (102) 102
prostate - drug effects (102) 102
enzyme inhibitors - therapeutic use (99) 99
5α-reductase inhibitors (97) 97
testosterone - blood (96) 96
rats, sprague-dawley (95) 95
enzymes (93) 93
metabolism (90) 90
aromatase (85) 85
5-alpha-reductase (84) 84
androgens - metabolism (84) 84
dose-response relationship, drug (84) 84
treatment outcome (84) 84
5α-reductase inhibitor (82) 82
progesterone (82) 82
adolescent (79) 79
aged, 80 and over (78) 78
receptors, androgen - metabolism (78) 78
5-alpha reductase inhibitors - pharmacology (77) 77
oncology (77) 77
urinary-tract symptoms (77) 77
risk (76) 76
receptor (74) 74
gene expression (73) 73
growth (73) 73
5-alpha reductase inhibitors - therapeutic use (71) 71
androgen (71) 71
brain (70) 70
prostate - enzymology (70) 70
estrogen (68) 68
dermatology (67) 67
bph (66) 66
dihydrotestosterone - blood (66) 66
oxidoreductases - genetics (66) 66
prostatic neoplasms - drug therapy (66) 66
steroids (65) 65
efficacy (64) 64
reductase (64) 64
cell biology (63) 63
cells, cultured (63) 63
adrenergic alpha-antagonists - therapeutic use (62) 62
prostate - metabolism (62) 62
rats, wistar (62) 62
rna, messenger - metabolism (62) 62
analysis (61) 61
gene-expression (61) 61
hypertrophy (61) 61
risk factors (60) 60
testosterone - pharmacology (60) 60
mutation (59) 59
tissue distribution (59) 59
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1795) 1795
Japanese (26) 26
German (20) 20
French (14) 14
Russian (12) 12
Chinese (9) 9
Spanish (5) 5
Italian (3) 3
Korean (2) 2
Polish (2) 2
Arabic (1) 1
Bulgarian (1) 1
Czech (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Science of the Total Environment, ISSN 0048-9697, 09/2016, Volume 563-564, pp. 566 - 575
Di-(2-ethylhexyl) phthalate (DEHP) has reproductive toxicity and can affect male reproductive development. In order to clarify adverse effects of DEHP on... 
5α-Reductase 2 | Hypothalamic–pituitary–testis axis | Testosterone | DEHP | ERK | Hypothalamic-pituitary-testis axis | STEROIDOGENESIS | ACTIVATION | LEYDIG-CELLS | DI(2-ETHYLHEXYL) PHTHALATE | ENVIRONMENTAL SCIENCES | DI(N-BUTYL) PHTHALATE | THYROID-HORMONES | HEPATOTOXICITY | 5 alpha-Reductase 2 | ADULT-RAT TESTIS | EXPOSURE | MODULATION | Index Medicus
Journal Article
NEUROPSYCHOPHARMACOLOGY, ISSN 0893-133X, 03/2016, Volume 41, Issue 4, pp. 1093 - 1102
Changes in neurosteroid levels during the luteal phase of the menstrual cycle may precipitate affective symptoms. To test this hypothesis, we stabilized... 
MENSTRUAL-CYCLE | HUMAN BRAIN | STEROIDS | PROGESTERONE | ANXIETY | PSYCHIATRY | SENSITIVITY | RECEPTOR | NEUROSCIENCES | MOOD DISORDERS | 5 ALPHA-PREGNANE-3,20-DIONE | PHARMACOLOGY & PHARMACY | EXPRESSION
Journal Article
Journal of Endocrinology, ISSN 0022-0795, 2017, Volume 232, Issue 1, pp. 29 - 36
Journal Article
Journal of Steroid Biochemistry and Molecular Biology, ISSN 0960-0760, 10/2016, Volume 163, pp. 206 - 211
Journal Article
Assay and Drug Development Technologies, ISSN 1540-658X, 02/2019, Volume 17, Issue 2, pp. 44 - 57
Human steroid 5 alpha-reductases (S5αRs) and NADPH irreversibly reduce testosterone to the more potent dihydrotestosterone (DHT). S5αR inhibitors are useful... 
5 alphareductase inhibition assay | natural steroid 5-alpha reductase inhibitors | drug discovery | antiandrogen | 5 alpha-reductase | Reductases | Isoenzymes | Acne | Medical treatment | Hyperplasia | High-throughput screening | Quantitation | Substrates | Testosterone | Screening | Dihydrotestosterone | Inhibitors | Alopecia | Transfection | NADP | Prostate | Steroids | Reductase
Journal Article
Current Pharmaceutical Design, ISSN 1381-6128, 01/2011, Volume 17, Issue 2, pp. 151 - 167
The enzyme steroid 5 alpha-reductase (S5 alpha R) catalyzes the conversion of Delta(4)-3-ketosteroid precursors-such as testosterone, progesterone and... 
DHT | Testosterone | Dopamine | Finasteride | Schizophrenia | Antipsychotic | Dutasteride | Steroid 5α-reductase | Progesterone | Tourette syndrome | Allopregnanolone | dutasteride | GABA(A) RECEPTOR FUNCTION | SENSORIMOTOR GATING DEFICITS | testosterone | progesterone | PROSTATE-CANCER RISK | C6 GLIOMA-CELLS | allopregnanolone | schizophrenia | MESSENGER-RNA LEVELS | HIGH-THROUGHPUT CLONING | OBSESSIVE-COMPULSIVE DISORDER | Steroid 5 alpha-reductase | ETHANOL WITHDRAWAL SEVERITY | PHARMACOLOGY & PHARMACY | antipsychotic | 5 ALPHA-REDUCTASE | CENTRAL-NERVOUS-SYSTEM | finasteride | dopamine | 5-alpha Reductase Inhibitors - chemistry | Schizophrenia - metabolism | 3-Oxo-5-alpha-Steroid 4-Dehydrogenase - chemistry | Humans | Mental Disorders - metabolism | Rats | Male | 5-alpha Reductase Inhibitors - therapeutic use | Molecular Targeted Therapy | Animals | Mental Disorders - drug therapy | 3-Oxo-5-alpha-Steroid 4-Dehydrogenase - genetics | 3-Oxo-5-alpha-Steroid 4-Dehydrogenase - metabolism | 5-alpha Reductase Inhibitors - pharmacology | Prostatic Neoplasms - enzymology | Female | Mice | Prostatic Neoplasms - prevention & control | Schizophrenia - drug therapy | Prostatic Hyperplasia - drug therapy | Enzymes | Hyperreactivity | Mental disorders | Hyperplasia | Nomenclature | impulsive behavior | Psychosis | Dihydrotestosterone | Alopecia | Reviews | Metabolites | steroid 5 alpha -reductase | Gilles de la Tourette syndrome | Androstenedione | Neurotransmission
Journal Article
Bioorganic & Medicinal Chemistry, ISSN 0968-0896, 02/2016, Volume 24, Issue 4, pp. 779 - 788
Journal Article
Strahlentherapie und Onkologie, ISSN 0179-7158, 1/2018, Volume 194, Issue 1, pp. 17 - 22
Journal Article